Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-18 06:07 am Purchase | 2023-09-11 | 13D | Check-Cap Ltd. CHEK | Symetryx Corp | 338,626 5.800% | 10,610 (+3.23%) | Filing History |
| 2023-11-27 3:33 pm Purchase | 2023-09-11 | 13D | Check-Cap Ltd. CHEK | Symetryx Corp | 328,016 5.600% | 27,152 (+9.02%) | Filing History |
| 2023-11-13 5:32 pm Unchanged | 2023-09-11 | 13D | Check-Cap Ltd. CHEK | Symetryx Corp | 300,864 5.100% | 0 (Unchanged) | Filing History |
| 2023-10-30 08:40 am Unchanged | 2023-09-11 | 13D | Check-Cap Ltd. CHEK | Symetryx Corp | 300,864 5.100% | 0 (Unchanged) | Filing History |
| 2023-09-29 1:46 pm Purchase | 2023-09-11 | 13D | Check-Cap Ltd. CHEK | Symetryx Corp | 300,864 5.100% | 300,864 (New Position) | Filing History |
| 2023-09-20 5:28 pm Sale | 2023-09-14 | 13D | NeuBase Therapeutics, Inc. NBSE | Symetryx Corp | 109,508 3.500% | -363,418 (-76.84%) | Filing History |
| 2023-09-14 06:03 am Purchase | 2023-09-08 | 13D | NeuBase Therapeutics, Inc. NBSE | Symetryx Corp | 472,926 9.100% | 44,482 (+10.38%) | Filing History |
| 2023-08-31 11:50 am Purchase | 2023-08-22 | 13D | NeuBase Therapeutics, Inc. NBSE | Symetryx Corp | 428,444 13.800% | 428,444 (New Position) | Filing History |